Novo Nordisk identifies a hacking incident; pseudoanonymized patient data from clinical trials and provider data accessed
Danish pharmaceutical firm Novo Nordisk, the world’s largest producer of insulin, and maker of GLP-1 medications Wegovy and Ozempic, has disclosed a data breach. The following is from its press release of June 11, 2026: Novo Nordisk A/S has identified an IT security incident involving unauthorised access to a limited number of internal IT systems. […]
